
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.960 | 5.960 | 0.000 |
Shares | 94.040 | 94.040 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 31.077 | 28.447 |
Price to Book | 8.878 | 6.668 |
Price to Sales | 9.017 | 4.878 |
Price to Cash Flow | 24.341 | 18.893 |
Dividend Yield | 0.403 | 0.697 |
5 Years Earnings Growth | 16.281 | 12.916 |
Name | Net % | Category Average |
---|---|---|
Technology | 39.950 | 36.345 |
Financial Services | 19.630 | 11.254 |
Healthcare | 14.000 | 13.080 |
Communication Services | 9.730 | 12.566 |
Consumer Cyclical | 9.100 | 14.375 |
Industrials | 7.580 | 7.889 |
Number of long holdings: 23
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA | US67066G1040 | 7.17 | 135.13 | -2.92% | |
Netflix | US64110L1061 | 7.09 | 1,207.23 | +1.89% | |
ASML ADR | USN070592100 | 6.81 | 736.77 | -1.38% | |
Visa A | US92826C8394 | 5.74 | 365.19 | +0.77% | |
Intuit | US4612021034 | 4.91 | 753.47 | -0.50% | |
Synopsys | US8716071076 | 4.78 | 463.98 | +1.98% | |
Airbnb | US0090661010 | 4.74 | 129.00 | +0.50% | |
S&P Global | US78409V1044 | 4.56 | 512.86 | -0.24% | |
Eli Lilly | US5324571083 | 4.44 | 737.67 | +2.09% | |
Intuitive Surgical | US46120E6023 | 4.39 | 552.34 | -0.61% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech B USD | 1.43B | 2.72 | 4.63 | 8.97 | ||
Adamant Medtech I USD | 1.43B | 2.96 | 5.36 | 9.75 | ||
LU1811047247 | 225.09M | -1.98 | 1.74 | - | ||
LU1811047593 | 225.09M | -2.21 | 1.03 | - | ||
Ashburton Global Leaders Equity Fud | 181.95M | 2.71 | 8.10 | 6.88 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review